Apr.09.2026Likang Life Sciences founder Chen Li explains how his Beijing startup is developing personalized mRNA cancer vaccines and why China’s biotech rise matters globally00:0000:00/00:00您的浏览器不支持 audio 标签。
Cancer treatment has long relied on a largely fixed set of options: surgery, radiation, chemotherapy and targeted drugs. But a new generation of biotech founders is trying to push the field toward something more precise — treatments built around the biology of a single patient.
In this debut episode of Darers & Doers, a special segment of the China Business Uncovered podcast, Likang Life Sciences Founder and CEO Chen Li explains how his Beijing-based biotech startup is using artificial intelligence to develop personalized mRNA cancer vaccines.
Open WeChat and scan the QR code
